Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic–pharmacody...

le Kerbusch, Thomas, Milligan, Peter A, Karlsson, Mats O
Foilsithe 2004

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

le Karlsson, Mats O., Lutsar, Irja, Milligan, Peter A.
Foilsithe 2009

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction

le Milligan, Peter A, Marshall, Scott F, Karlsson, Mats O
Foilsithe 2002

Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulatio...

le Kerbusch, Thomas, Wählby, Ulrika, Milligan, Peter A, Karlsson, Mats O
Foilsithe 2003

Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis

le Wählby, Ulrika, Thomson, Alison H, Milligan, Peter A, Karlsson, Mats O
Foilsithe 2004

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

le Walsh, Thomas J., Driscoll, Timothy, Milligan, Peter A., Wood, Nolan D., Schlamm, Haran, Groll, Andreas H., Jafri, Hasan, Arrieta, Antonio C., Klein, Nigel J., Lutsar, Irja
Foilsithe 2010